Hochhauser Edith, Avlas Orna, Fallach Reut, Bachmetov Larissa, Zemel Romy, Pappo Orit, Shainberg Asher, Ben Ari Ziv
Felsenstein Medical Research Center, Rabin Medical Center, Petach Tikva, Israel.
PLoS One. 2013 Aug 15;8(8):e73041. doi: 10.1371/journal.pone.0073041. eCollection 2013.
Toll-like receptors (TLRs) are expressed in immune cells and hepatocytes. We examined whether hepatic Toll-like receptor 4 (TLR4) is involved in the acute hepatic injury caused by the administration of lipopolysaccharide (LPS) (septic shock model).
Wild type (WT), TLR4-deficient and chimera mice underwent myeloablative bone marrow transplantation to dissociate between TLR4 expression in the liver or in the immune-hematopoietic system. Mice were injected with LPS and sacrificed 4 hours later.
Compared to TLR4 deficient mice, WT mice challenged with LPS displayed increased serum liver enzymes and hepatic cellular inflammatory infiltrate together with increased serum and hepatic levels of interleukin 1β (IL-1β), tumor necrosis factor α (TNFα) ,Up-regulation of hepatic mRNA encoding TLR4, IκB and c-jun expressions. TLR4 mutant mice transplanted with WT bone marrow were more protected than WT chimeric mice bearing TLR4 mutant hemopoietic cells from LPS, as seen by IL-1β and TNFα levels. We then used hepatocytes (Huh7) and macrophages from monocytic cell lines to detect TLR mRNA expression. Macrophages expressed a significantly higher level of TLR4 mRNA and TLR2 (more than 3000- and 8000-fold respectively) compared with the hepatocyte cell line. LPS administration induced TLR4 activation in a hepatocyte cell line in a dose dependent manner while TLR2 mRNA hardly changed.
These results suggest that TLR4 activation of hepatocytes participate in the immediate response to LPS induced hepatic injury. However, in this response, the contribution of TLR4 on bone marrow derived cells is more significant than those of the hepatocytes. The absence of the TLR4 gene plays a pivotal role in reducing hepatic LPS induced injury.
Toll样受体(TLRs)在免疫细胞和肝细胞中表达。我们研究了肝脏Toll样受体4(TLR4)是否参与脂多糖(LPS)给药所致的急性肝损伤(脓毒症休克模型)。
野生型(WT)、TLR4缺陷型和嵌合小鼠接受清髓性骨髓移植,以区分肝脏或免疫造血系统中TLR4的表达。给小鼠注射LPS,4小时后处死。
与TLR4缺陷型小鼠相比,用LPS攻击的WT小鼠血清肝酶升高,肝细胞炎性浸润增加,同时血清和肝脏中白细胞介素1β(IL-1β)、肿瘤坏死因子α(TNFα)水平升高,肝脏中编码TLR4、IκB和c-jun的mRNA表达上调。从IL-1β和TNFα水平可见,移植WT骨髓的TLR4突变小鼠比带有TLR4突变造血细胞的WT嵌合小鼠对LPS更具抵抗力。然后我们使用肝细胞(Huh7)和单核细胞系的巨噬细胞来检测TLR mRNA表达。与肝细胞系相比,巨噬细胞中TLR4 mRNA和TLR2的表达水平显著更高(分别超过3000倍和8000倍)。LPS给药以剂量依赖性方式诱导肝细胞系中TLR4活化,而TLR2 mRNA几乎没有变化。
这些结果表明,肝细胞的TLR4活化参与了对LPS诱导的肝损伤的即时反应。然而,在这种反应中,TLR4对骨髓来源细胞的作用比肝细胞更显著。TLR4基因的缺失在减轻肝脏LPS诱导的损伤中起关键作用。